Antibody Therapy in Non-Hodgkin’s Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, and Alemtuzumab
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-540-46091-6_13.pdf
Reference53 articles.
1. Ansell SM, Schilder RJ, Pieslor PC, et al (2004) Antilymphoma treatments given subsequent to yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin’s lymphoma: a review of the literature. Clin Lymphoma 5:202–204
2. Berinstein NL, Grillo-López AJ, White CA, et al (1998) Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma. Ann Oncol 9:995–1001
3. Cartron G, Watier H, Golay J, et al (2004) From the bench to the bedside: ways to improve rituximab efficacy. Blood 104:2635–2642
4. Cheson BD (2005) The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma. BioDrugs 19:309–322
5. Cheson BD (2006) Monoclonal antibody therapy of chronic lymphocytic leukemia. Cancer Immunol Immunother 55:188–196
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy;Journal of Materials Chemistry B;2022
2. Molecular Pathology of Malignant Lymphoma;Surgical Pathology Clinics;2012-12
3. Preparation of human scFv antibody against nasopharyngeal carcinoma and identification of its specificity;Acta Oto-Laryngologica;2012-04-12
4. Antibodies for Human Diseases;Pharmaceutical Sciences Encyclopedia;2011-12-16
5. Construction and Selection of Human Fab Antibody Phage Display Library of Liver Cancer;Hybridoma;2009-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3